Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Chemoradiation in Locally Advanced Pancreatic Cancer
NCT00424827Phase 2Completed
- Sponsor
- University of Massachusetts
- Start
- Jun 2006
- Primary completion
- Dec 2014
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of KL-140 in pancreatic adenocarcinoma (PDAC), sponsored by University of Massachusetts. Started Jun 2006; status: completed.
02
Drugs
KL-140
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00424827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424827.